This section will focus on three enzymes, CD73, HO-1 and TDO2, that were identified by manipulating breast cancer EMT by our group [30] and the Weinberg group [23] and summarize how each may impact breast cancer metastasis and anti-tumor immunity. Here, NT5E is linked to breast carcinoma.